CMA drops probe into Merck’s Remicade discounts

Janith Aranze

14 March 2019

CMA drops probe into Merck’s Remicade discounts

Credit: istock/Svisio

The UK’s antitrust enforcer has closed its abuse of dominance investigation into Merck Sharp & Dohme’s discount scheme, despite finding no “procompetitive rationale or efficiency justification” for the conduct.